Tetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor primarily used in the symptomatic treatment of hyperkinetic movement disorders such as chorea associated with Huntington’s disease.… Read more











![Chemical structure of (2R,3S,11bS)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F924854-62-6-2R3S11bS-1346711b-Hexahydro-910-dimethoxy-3-2-methylpropyl-2H-benzoaquinolizin-2-ol.png&w=3840&q=75)
![Chemical structure of (2R,3S,11bS)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol ((1S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate (1:1)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2R3S11bS-3-Isobutyl-910-dimethoxy-1346711b-hexahydro-2H-pyrido21-aisoquinolin-2-ol-1S-77-dimethyl-2-oxobicyclo2.2.1heptan-1-ylmethanesulfonate-11.png&w=3840&q=75)


![Chemical structure of (2S,3R,11bR)-3-isobutyl-10-methoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline-2,9-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1214267-68-1-2S3R11bR-3-isobutyl-10-methoxy-1346711b-hexahydro-2H-pyrido21-aisoquinoline-29-diol.png&w=3840&q=75)


![Chemical structure of (2S,3S,11bS)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F164104-49-8-2S3S11bS-3-Isobutyl-910-dimethoxy-1346711b-hexahydro-2H-pyrido21-aisoquinolin-2-ol.png&w=3840&q=75)
![Chemical structure of (3R)-3-Isobutyl-9,10-dimethoxy-2-oxo-1,3,4,6,7,11b-hexahydropyrido[2,1-a]isoquinoline 5(2H)-Oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3R-3-Isobutyl-910-dimethoxy-2-oxo-1346711b-hexahydropyrido21-aisoquinoline-52H-Oxide.png&w=3840&q=75)




![Chemical structure of (3S,11bR)-3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3S11bR-3-Isobutyl-910-dimethoxy-3467-tetrahydro-1H-pyrido21-aisoquinolin-211bH-one.png&w=3840&q=75)



![Chemical structure of (R)-3-Isobutyl-9,10-dimethoxy-1,6,7,11b-tetrahydro-4H-pyrido[2,1-a]isoquinoline](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F920265-21-0-R-3-Isobutyl-910-dimethoxy-16711b-tetrahydro-4H-pyrido21-aisoquinoline.png&w=3840&q=75)


![Chemical structure of 1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-1-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F99672-64-7-1346711b-Hexahydro-910-dimethoxy-1-2-methylpropyl-2H-benzoaquinolizin-2-one.png&w=3840&q=75)
![Chemical structure of 1,3,4,6,7,11b-Hexahydro-9-hydroxy-10-methoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F149183-89-1-1346711b-Hexahydro-9-hydroxy-10-methoxy-3-2-methylpropyl-2H-benzoaquinolizin-2-one.png&w=3840&q=75)







![Chemical structure of 3-Butyl-9,10-Dimethoxy-1,3,4,6,7,11b-Hexahydro-2H-pyrido[2,1-a]Isoquinolin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F19328-35-9-3-Butyl-910-Dimethoxy-1346711b-Hexahydro-2H-pyrido21-aIsoquinolin-2-one.png&w=3840&q=75)

![Chemical structure of 3-Isobutyl-9,10-bis(methoxy-d3)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1351951-64-8-3-Isobutyl-910-bismethoxy-d3-1346711b-hexahydro-2H-pyrido21-aisoquinolin-2-ol.png&w=3840&q=75)
![Chemical structure of 3-Isobutyl-9,10-bis(methoxy-d3)-3,4,6,7-tetrahydro-2H-pyrido[2,1-a]isoquinolin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2244238-17-1-3-Isobutyl-910-bismethoxy-d3-3467-tetrahydro-2H-pyrido21-aisoquinolin-2-one.png&w=3840&q=75)
![Chemical structure of 3-Isobutyl-9,10-bis(methoxy-d3)-6,7-dihydro-2H-pyrido[2,1-a]isoquinolin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-Isobutyl-910-bismethoxy-d3-67-dihydro-2H-pyrido21-aisoquinolin-2-one.png&w=3840&q=75)
![Chemical structure of 3-Isobutyl-9,10-dimethoxy-6,7-dihydro-2H-pyrido[2,1-a]isoquinolin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3-Isobutyl-910-dimethoxy-67-dihydro-2H-pyrido21-aisoquinolin-2-one.png&w=3840&q=75)




Tetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor primarily used in the symptomatic treatment of hyperkinetic movement disorders such as chorea associated with Huntington’s disease. As a reversible monoamine-depleting agent, it acts within the central nervous system to reduce the availability of dopamine, serotonin, and norepinephrine. In pharmaceutical research and quality control, laboratories rely on high-quality reference standards for Tetrabenazine to ensure therapeutic safety and regulatory compliance. This category includes the parent drug API, its pharmacopeial and non-pharmacopeial impurities, synthetic intermediates, degradation products, and stable isotope labelled compounds. These materials are essential for robust impurity profiling, method validation, and stability testing, enabling scientists to accurately monitor drug quality and identify potential contaminants throughout the development and manufacturing lifecycle. Such analytical standards support adherence to international quality guidelines for medicinal products.